HEADER HYDROLASE 18-JAN-06 2FQQ TITLE CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS285->ALA, CYS362->ALA, TITLE 2 CYS364->ALA, CYS397->ALA) IN COMPLEX WITH 1-METHYL-3-TRIFLUOROMETHYL- TITLE 3 1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P20 SUBUNIT, RESIDUES 120-297; COMPND 5 EC: 3.4.22.36; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CASPASE-1; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: P10 SUBUNIT, RESIDUES 317-404; COMPND 12 EC: 3.4.22.36; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP1, IL1BC, IL1BCE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON+; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSET; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CASP1, IL1BC, IL1BCE; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON+; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PRSET KEYWDS CASPASE, ALLOSTERIC INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.SCHEER,J.A.WELLS,M.J.ROMANOWSKI REVDAT 4 20-OCT-21 2FQQ 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 2FQQ 1 VERSN REVDAT 2 24-FEB-09 2FQQ 1 VERSN REVDAT 1 16-MAY-06 2FQQ 0 JRNL AUTH J.M.SCHEER,M.J.ROMANOWSKI,J.A.WELLS JRNL TITL A COMMON ALLOSTERIC SITE AND MECHANISM IN CASPASES JRNL REF PROC.NATL.ACAD.SCI.USA V. 103 7595 2006 JRNL REFN ISSN 0027-8424 JRNL PMID 16682620 JRNL DOI 10.1073/PNAS.0602571103 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 5225 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 247 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.41 REMARK 3 REFLECTION IN BIN (WORKING SET) : 526 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.28 REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE SET COUNT : 23 REMARK 3 BIN FREE R VALUE : 0.2680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1861 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 18 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.51000 REMARK 3 B22 (A**2) : 4.51000 REMARK 3 B33 (A**2) : -6.77000 REMARK 3 B12 (A**2) : 2.26000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.567 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.464 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 62.137 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.896 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.817 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1922 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2596 ; 1.119 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 233 ; 3.259 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 86 ;35.744 ;23.721 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 340 ;15.756 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;10.942 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 286 ; 0.042 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1442 ; 0.001 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 813 ; 0.123 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1310 ; 0.284 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 66 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 59 ; 0.071 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.165 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 1 REMARK 3 ORIGIN FOR THE GROUP (A): 41.0054 28.1484 34.1417 REMARK 3 T TENSOR REMARK 3 T11: -0.0336 T22: 0.0431 REMARK 3 T33: 0.0474 T12: -0.0256 REMARK 3 T13: -0.0790 T23: -0.0631 REMARK 3 L TENSOR REMARK 3 L11: 2.0237 L22: 2.3744 REMARK 3 L33: 3.4920 L12: 0.5489 REMARK 3 L13: -0.0107 L23: -0.3812 REMARK 3 S TENSOR REMARK 3 S11: 0.1940 S12: 0.1254 S13: -0.2335 REMARK 3 S21: 0.1190 S22: -0.0511 S23: -0.0197 REMARK 3 S31: 0.3250 S32: -0.1542 S33: -0.1428 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FQQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000036197. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5490 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1SC1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MM HEPES, 16.5% PEG 3350, 250 MM REMARK 280 (NH4)2SO4, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.50733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.25367 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.25367 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 78.50733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: HETEROTETRAMER (DIMER OF TWO HETERODIMERS). EACH REMARK 300 HETERODIMER IS REPRESENTED BY CHAINS A (THE P20 SUBUNIT) AND B (THE REMARK 300 P10 SUBUNIT) OF HUMAN CASPASE-1. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 13870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -76.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 106.56600 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 61.52591 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 78.50733 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 120 REMARK 465 PRO A 121 REMARK 465 ALA A 122 REMARK 465 MET A 123 REMARK 465 PRO A 124 REMARK 465 THR A 125 REMARK 465 SER A 126 REMARK 465 SER A 127 REMARK 465 GLY A 128 REMARK 465 SER A 129 REMARK 465 GLU A 130 REMARK 465 GLY A 131 REMARK 465 ASN A 132 REMARK 465 VAL A 133 REMARK 465 LYS A 134 REMARK 465 LEU A 135 REMARK 465 CYS A 136 REMARK 465 SER A 137 REMARK 465 LEU A 138 REMARK 465 GLU A 139 REMARK 465 GLU A 140 REMARK 465 ALA A 141 REMARK 465 GLN A 142 REMARK 465 ARG A 143 REMARK 465 ILE A 144 REMARK 465 TRP A 145 REMARK 465 LYS A 146 REMARK 465 GLN A 147 REMARK 465 LYS A 148 REMARK 465 SER A 149 REMARK 465 ALA A 150 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 240 CB CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 205 83.33 51.20 REMARK 500 ILE A 239 -163.78 -124.60 REMARK 500 PRO A 290 125.59 -31.36 REMARK 500 HIS B 342 79.06 59.33 REMARK 500 SER B 363 -31.69 -148.39 REMARK 500 ASP B 381 -43.77 -138.80 REMARK 500 PHE B 401 85.65 58.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE F1G B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SC1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN REMARK 900 CASPASE-1 C285A MUTANT REMARK 900 RELATED ID: 1SC3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX REMARK 900 WITH MALONATE REMARK 900 RELATED ID: 1SC4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT AFTER REMOVAL REMARK 900 OF MALONATE REMARK 900 RELATED ID: 2FQR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF WILDTYPE HUMAN CASPASE-1 IN COMPLEX WITH 3-(2-{ REMARK 900 2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3-METHYL- REMARK 900 BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4-TRIOL (Z-VAD-FMK) REMARK 900 RELATED ID: 2FQS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA) IN COMPLEX WITH REMARK 900 3-(2-{2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3- REMARK 900 METHYL-BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4-TRIOL (Z- REMARK 900 VAD-FMK) REMARK 900 RELATED ID: 2FQU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ALA) IN COMPLEX WITH REMARK 900 3-(2-{2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3- REMARK 900 METHYL-BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4-TRIOL (Z- REMARK 900 VAD-FMK) REMARK 900 RELATED ID: 2FQV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA, GLU390->ALA) IN REMARK 900 COMPLEX WITH 3-(2-{2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1- REMARK 900 HYDROXY-3-METHYL-BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4- REMARK 900 TRIOL (Z-VAD-FMK) DBREF 2FQQ A 120 297 UNP P29466 CASP1_HUMAN 120 297 DBREF 2FQQ B 317 404 UNP P29466 CASP1_HUMAN 317 404 SEQADV 2FQQ ALA A 285 UNP P29466 CYS 285 ENGINEERED MUTATION SEQADV 2FQQ ALA B 362 UNP P29466 CYS 362 ENGINEERED MUTATION SEQADV 2FQQ ALA B 364 UNP P29466 CYS 364 ENGINEERED MUTATION SEQADV 2FQQ ALA B 397 UNP P29466 CYS 397 ENGINEERED MUTATION SEQRES 1 A 178 ASN PRO ALA MET PRO THR SER SER GLY SER GLU GLY ASN SEQRES 2 A 178 VAL LYS LEU CYS SER LEU GLU GLU ALA GLN ARG ILE TRP SEQRES 3 A 178 LYS GLN LYS SER ALA GLU ILE TYR PRO ILE MET ASP LYS SEQRES 4 A 178 SER SER ARG THR ARG LEU ALA LEU ILE ILE CYS ASN GLU SEQRES 5 A 178 GLU PHE ASP SER ILE PRO ARG ARG THR GLY ALA GLU VAL SEQRES 6 A 178 ASP ILE THR GLY MET THR MET LEU LEU GLN ASN LEU GLY SEQRES 7 A 178 TYR SER VAL ASP VAL LYS LYS ASN LEU THR ALA SER ASP SEQRES 8 A 178 MET THR THR GLU LEU GLU ALA PHE ALA HIS ARG PRO GLU SEQRES 9 A 178 HIS LYS THR SER ASP SER THR PHE LEU VAL PHE MET SER SEQRES 10 A 178 HIS GLY ILE ARG GLU GLY ILE CYS GLY LYS LYS HIS SER SEQRES 11 A 178 GLU GLN VAL PRO ASP ILE LEU GLN LEU ASN ALA ILE PHE SEQRES 12 A 178 ASN MET LEU ASN THR LYS ASN CYS PRO SER LEU LYS ASP SEQRES 13 A 178 LYS PRO LYS VAL ILE ILE ILE GLN ALA ALA ARG GLY ASP SEQRES 14 A 178 SER PRO GLY VAL VAL TRP PHE LYS ASP SEQRES 1 B 88 ALA ILE LYS LYS ALA HIS ILE GLU LYS ASP PHE ILE ALA SEQRES 2 B 88 PHE CYS SER SER THR PRO ASP ASN VAL SER TRP ARG HIS SEQRES 3 B 88 PRO THR MET GLY SER VAL PHE ILE GLY ARG LEU ILE GLU SEQRES 4 B 88 HIS MET GLN GLU TYR ALA ALA SER ALA ASP VAL GLU GLU SEQRES 5 B 88 ILE PHE ARG LYS VAL ARG PHE SER PHE GLU GLN PRO ASP SEQRES 6 B 88 GLY ARG ALA GLN MET PRO THR THR GLU ARG VAL THR LEU SEQRES 7 B 88 THR ARG ALA PHE TYR LEU PHE PRO GLY HIS HET F1G B 1 19 HETNAM F1G 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5- HETNAM 2 F1G CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE FORMUL 3 F1G C10 H10 F3 N3 O S2 FORMUL 4 HOH *18(H2 O) HELIX 1 1 ASP A 157 ARG A 161 5 5 HELIX 2 2 GLY A 181 LEU A 196 1 16 HELIX 3 3 THR A 207 HIS A 220 1 14 HELIX 4 4 ARG A 221 SER A 227 5 7 HELIX 5 5 LEU A 258 ASN A 263 1 6 HELIX 6 6 CYS A 270 LYS A 274 5 5 HELIX 7 7 SER B 347 TYR B 360 1 14 HELIX 8 8 ASP B 365 PHE B 377 1 13 SHEET 1 A 6 SER A 199 LYS A 204 0 SHEET 2 A 6 LEU A 164 CYS A 169 1 N ILE A 167 O ASP A 201 SHEET 3 A 6 THR A 230 HIS A 237 1 O VAL A 233 N ILE A 168 SHEET 4 A 6 LYS A 278 ALA A 285 1 O VAL A 279 N LEU A 232 SHEET 5 A 6 PHE B 327 SER B 332 1 O ILE B 328 N ILE A 280 SHEET 6 A 6 PRO B 387 GLU B 390 -1 O GLU B 390 N ALA B 329 SHEET 1 B 2 GLY A 242 CYS A 244 0 SHEET 2 B 2 ILE A 255 GLN A 257 -1 O LEU A 256 N ILE A 243 LINK S1 F1G B 1 SG CYS B 331 1555 1555 1.81 SITE 1 AC1 6 LEU A 258 PHE A 262 ARG A 286 CYS B 331 SITE 2 AC1 6 GLU B 390 ARG B 391 CRYST1 71.044 71.044 117.761 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014076 0.008127 0.000000 0.00000 SCALE2 0.000000 0.016253 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008492 0.00000 MASTER 376 0 1 8 8 0 2 6 0 0 0 21 END